Display options
Share it on

Pain. 2021 Jul 02; doi: 10.1097/j.pain.0000000000002391. Epub 2021 Jul 02.

Mitochondrial calcium uniporter deletion prevents painful diabetic neuropathy by restoring mitochondrial morphology and dynamics.

Pain

Dale S George, Sandra Hackelberg, Nirupa D Jayaraj, Dongjun Ren, Seby L Edassery, Craig Rathwell, Rachel E Miller, Anne-Marie Malfait, Jeffrey N Savas, Richard J Miller, Daniela M Menichella

Affiliations

  1. Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA, Department of Pharmacology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA, Department of Internal Medicine, Rush Medical College, Chicago, IL, USA.

PMID: 34232927 PMCID: PMC8720329 DOI: 10.1097/j.pain.0000000000002391

Abstract

ABSTRACT: Painful diabetic neuropathy (PDN) is an intractable complication affecting 25% of diabetic patients. PDN is characterized by neuropathic pain accompanied by dorsal root ganglion (DRG) nociceptor hyperexcitability, resulting in calcium overload, axonal degeneration, and loss of cutaneous innervation. The molecular pathways underlying these effects are unknown. Using high-throughput and deep-proteome profiling, we found that mitochondrial fission proteins were elevated in DRG neurons from mice with PDN induced by a high-fat diet (HFD). In vivo calcium imaging revealed increased calcium signaling in DRG nociceptors from mice with PDN. Furthermore, using electron microscopy, we showed that mitochondria in DRG nociceptors had fragmented morphology as early as two weeks after starting HFD, preceding the onset of mechanical allodynia and small-fiber degeneration. Moreover, preventing calcium entry into the mitochondria, by selectively deleting the mitochondrial calcium uniporter (MCU) from these neurons restored normal mitochondrial morphology, prevented axonal degeneration, and reversed mechanical allodynia in the HFD mouse model of PDN. These studies suggest a molecular cascade linking neuropathic pain to axonal degeneration in PDN. In particular, nociceptor hyperexcitability and the associated increased intracellular calcium concentrations could lead to excessive calcium entry into mitochondria mediated by the MCU, resulting in increased calcium-dependent mitochondrial fission and ultimately contributing to small-fiber degeneration and neuropathic pain in PDN. Hence, we propose that targeting calcium entry into nociceptor mitochondria may represent a promising effective and disease-modifying therapeutic approach for this currently intractable and widespread affliction. Moreover, these results are likely to inform studies of other neurodegenerative disease involving similar underlying events.

Copyright © 2021 International Association for the Study of Pain.

References

  1. Cell Rep. 2015 Jul 7;12(1):23-34 - PubMed
  2. Annu Rev Pathol. 2020 Jan 24;15:235-259 - PubMed
  3. PLoS One. 2013 Oct 22;8(10):e77986 - PubMed
  4. Nat Methods. 2007 Mar;4(3):207-14 - PubMed
  5. Pain. 2016 Feb;157 Suppl 1:S53-S59 - PubMed
  6. Acta Neuropathol. 2010 Oct;120(4):477-89 - PubMed
  7. Neuron. 2008 Dec 10;60(5):748-66 - PubMed
  8. J Peripher Nerv Syst. 2014 Jun;19(2):77-87 - PubMed
  9. J Pain. 2009 Sep;10(9):895-926 - PubMed
  10. Trends Cell Biol. 2010 Feb;20(2):102-12 - PubMed
  11. JAMA. 2015 Sep 8;314(10):1021-9 - PubMed
  12. Brain Behav Immun. 2007 Jul;21(5):581-91 - PubMed
  13. Nucleic Acids Res. 2019 Jan 8;47(D1):D801-D806 - PubMed
  14. Anal Chem. 2015 Nov 17;87(22):11361-7 - PubMed
  15. Clin J Pain. 2012 Oct;28(8):726-43 - PubMed
  16. J Neurosci Methods. 2016 Mar 15;262:56-65 - PubMed
  17. Nat Rev Neurol. 2011 Sep 13;7(10):573-83 - PubMed
  18. Subcell Biochem. 2007;45:481-506 - PubMed
  19. Neurology. 2007 Jul 3;69(1):42-9 - PubMed
  20. Brain. 2004 Jul;127(Pt 7):1593-605 - PubMed
  21. Diabet Med. 2016 May;33(5):650-4 - PubMed
  22. J Biol Chem. 2017 Sep 1;292(35):14473-14485 - PubMed
  23. ACS Cent Sci. 2019 Jan 23;5(1):153-166 - PubMed
  24. Diabetes Care. 2011 Jan;34 Suppl 1:S62-9 - PubMed
  25. Nature. 2010 Sep 16;467(7313):291-6 - PubMed
  26. J Neurophysiol. 2015 Sep;114(3):1554-64 - PubMed
  27. Biochem Biophys Res Commun. 2015 Jun 5;461(3):537-42 - PubMed
  28. Diabetes. 2007 Oct;56(10):2598-608 - PubMed
  29. Pain. 2012 Oct;153(10):2017-2030 - PubMed
  30. Lancet Diabetes Endocrinol. 2014 Jan;2(1):56-64 - PubMed
  31. Acta Neuropathol. 2015 Jan;129(1):81-96 - PubMed
  32. Dev Cell. 2014 Oct 13;31(1):48-60 - PubMed
  33. eNeuro. 2017 Nov 21;4(6): - PubMed
  34. Nat Clin Pract Neurol. 2007 Oct;3(10):546-57 - PubMed
  35. Science. 2013 Dec 13;342(6164):1379-82 - PubMed
  36. J Pain. 2014 Dec;15(12):1338-1359 - PubMed
  37. J Appl Physiol (1985). 2013 Jan 15;114(2):161-71 - PubMed
  38. Brain. 2012 Jun;135(Pt 6):1751-66 - PubMed
  39. Eur J Pain. 2011 May;15(5):441-3 - PubMed
  40. Arthritis Rheumatol. 2018 Jan;70(1):88-97 - PubMed
  41. J Comp Neurol. 2000 Nov 20;427(3):340-50 - PubMed
  42. J Clin Invest. 2018 Jun 1;128(6):2205-2225 - PubMed
  43. Pain. 2015 Nov;156(11):2175-2183 - PubMed
  44. Cell Rep. 2015 Jul 7;12(1):15-22 - PubMed
  45. Proc Natl Acad Sci U S A. 2008 Oct 14;105(41):15803-8 - PubMed
  46. J Pain Res. 2011;4:169-75 - PubMed
  47. Histopathology. 2009 Feb;54(3):273-85 - PubMed
  48. Lancet Neurol. 2012 Jun;11(6):521-34 - PubMed
  49. Pain Med. 2011 Jan;12(1):118-26 - PubMed
  50. Nature. 2011 Jun 19;476(7360):336-40 - PubMed
  51. Cell Calcium. 2010 Feb;47(2):130-9 - PubMed
  52. Prog Neurobiol. 2006 Dec;80(5):241-68 - PubMed
  53. Curr Pharm Des. 2011 Dec;17(37):4147-58 - PubMed
  54. Diabetes Care. 2017 Jan;40(1):136-154 - PubMed
  55. Cell Rep. 2019 Apr 30;27(5):1541-1550.e5 - PubMed
  56. EMBO J. 2013 Aug 28;32(17):2362-76 - PubMed
  57. Neurobiol Dis. 2013 Mar;51:56-65 - PubMed
  58. Lancet Neurol. 2007 Jul;6(7):632-42 - PubMed
  59. Nat Cell Biol. 2013 Dec;15(12):1464-72 - PubMed
  60. J Exp Biol. 2003 Jun;206(Pt 12):1985-92 - PubMed
  61. Apoptosis. 2007 May;12(5):815-33 - PubMed
  62. J Lipid Res. 2019 Jan;60(1):58-70 - PubMed
  63. J Cell Biol. 2012 Jan 9;196(1):7-18 - PubMed
  64. Neurology. 2003 Sep 9;61(5):631-6 - PubMed
  65. Anal Chem. 2014 Jul 15;86(14):7150-8 - PubMed
  66. PLoS One. 2018 Dec 10;13(12):e0208596 - PubMed
  67. Cell. 2009 Oct 16;139(2):267-84 - PubMed
  68. Bio Protoc. 2017 Aug 20;7(16): - PubMed
  69. Neuron. 1998 Apr;20(4):629-32 - PubMed
  70. Nature. 2013 Jul 18;499(7458):295-300 - PubMed
  71. EMBO Rep. 2007 Oct;8(10):939-44 - PubMed
  72. Bioinformatics. 2014 Aug 1;30(15):2208-9 - PubMed
  73. Expert Opin Ther Targets. 2020 Mar;24(3):163-169 - PubMed
  74. Nat Cell Biol. 2012 Dec;14(12):1336-43 - PubMed
  75. Trends Mol Med. 2016 May;22(5):377-390 - PubMed
  76. Neuron. 2012 Feb 23;73(4):638-52 - PubMed
  77. Diabetologia. 2002 Apr;45(4):560-70 - PubMed
  78. Cell Rep. 2014 Apr 10;7(1):1-11 - PubMed
  79. J Cell Biol. 2010 Dec 13;191(6):1141-58 - PubMed
  80. Mol Pain. 2016 Sep 02;12: - PubMed
  81. Mol Biol Cell. 2013 Mar;24(5):659-67 - PubMed
  82. J Cell Mol Med. 2019 Nov;23(11):7830-7843 - PubMed
  83. Neurology. 1991 Jun;41(6):799-807 - PubMed
  84. Diabetes. 2010 Apr;59(4):1082-91 - PubMed
  85. Differentiation. 2009 Apr;77(4):395-411 - PubMed
  86. Sci Adv. 2020 May 06;6(19):eaax9093 - PubMed
  87. Pain. 2005 Jan;113(1-2):27-36 - PubMed
  88. Trends Neurosci. 2002 Oct;25(10):532-7 - PubMed
  89. Pain. 2018 Sep;159(9):1867-1876 - PubMed
  90. Eur J Neurosci. 1996 Oct;8(10):2204-8 - PubMed
  91. Elife. 2014 Dec 19;3: - PubMed
  92. Trends Biochem Sci. 2020 Jul;45(7):564-577 - PubMed
  93. J Neurosci. 2006 Nov 1;26(44):11287-94 - PubMed
  94. Curr Drug Targets. 2008 Jan;9(1):3-13 - PubMed
  95. Pain. 2009 Nov;146(1-2):34-40 - PubMed
  96. J Neurochem. 1996 Feb;66(2):493-500 - PubMed
  97. Nucleic Acids Res. 2016 Jan 4;44(D1):D1251-7 - PubMed
  98. Pain. 2016 May;157(5):1132-1145 - PubMed
  99. J Physiol. 2002 Nov 15;545(1):43-50 - PubMed
  100. Adv Exp Med Biol. 2017;982:25-47 - PubMed
  101. Lancet Neurol. 2012 Nov;11(11):999-1005 - PubMed
  102. Genes Brain Behav. 2007 Jul;6(5):425-31 - PubMed
  103. J Neurosci. 2015 Nov 11;35(45):15026-38 - PubMed
  104. Diabetologia. 2010 Jan;53(1):160-9 - PubMed
  105. Mol Cell. 2017 Aug 17;67(4):711-723.e7 - PubMed
  106. J Neurophysiol. 1999 Dec;82(6):3359-66 - PubMed
  107. Mol Pain. 2014 Jun 25;10:42 - PubMed
  108. Cell Rep. 2020 Feb 18;30(7):2321-2331.e6 - PubMed
  109. Diabetes Care. 2011 Oct;34(10):2220-4 - PubMed
  110. Nat Neurosci. 2015 Jan;18(1):145-53 - PubMed
  111. Nat Med. 2012 Jun;18(6):926-33 - PubMed
  112. Biochem Biophys Res Commun. 2014 Jul 11;449(4):384-5 - PubMed
  113. Cell Res. 2016 Aug;26(8):967 - PubMed
  114. J Neurosci Res. 2016 Jul;94(7):653-70 - PubMed
  115. Nature. 2011 Jun 19;476(7360):341-5 - PubMed
  116. Int Rev Neurobiol. 2019;145:127-176 - PubMed
  117. EMBO Rep. 2017 Aug;18(8):1397-1411 - PubMed
  118. Biochim Biophys Acta. 2016 Oct;1863(10):2457-64 - PubMed
  119. J Cell Biol. 2008 Aug 11;182(3):573-85 - PubMed
  120. Trends Neurosci. 2012 Jun;35(6):364-72 - PubMed
  121. Pain. 2017 Aug;158(8):1446-1455 - PubMed

Publication Types

Grant support